Skip Navigation

Annals of Oncology 2007 18(9):1513-1517; doi:10.1093/annonc/mdm192
This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow E-letters: Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when E-letters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (3)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Coutant, C
Right arrow Articles by Darai, E
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Coutant, C
Right arrow Articles by Darai, E
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© 2007 European Society for Medical Oncology

gynecologic tumors

Frequency and prognostic significance of HPV DNA in sentinel lymph nodes of patients with cervical cancer

C Coutant1,2, E Barranger2, A Cortez3, D Dabit3, S Uzan2, JF Bernaudin1 and E Darai2,*

1 Departments of Histology and Tumor Biology
2 Gynecology and Obstetrics
3 Pathology, Hôpital Tenon, Assistance Publique des Hôpitaux de Paris, CancerEst, Université Pierre et Marie Curie Paris VI, Paris, France

* Correspondence to: Prof. E. Daraï, Department of Gynecologic and Obstetrics, Hôpital Tenon, 4 rue de la Chine, 75020 Paris, France. Tel: +33-156-016-849; Fax: +33-156-016-062; E-mail: emile.darai{at}tnn.aphp.fr

Background: It has been suggested that histologically undetectable or ‘occult’ metastases in the lymphatic system could explain some recurrences. HPV DNA screening by means of the polymerase chain reaction (PCR) has been proposed as a method to detect occult metastases. This study was designed to determine the frequency of HPV DNA detection by PCR in sentinel lymph node (SN), and its relation to the clinical characteristics and outcome of women with cervical cancer.

Patients and methods: The primary cervical tumor and SN were tested for HPV DNA by means of PCR in 59 patients.

Results: Fifteen (25.4%) of the 59 women undergoing the SN procedure had an involved SN. HPV DNA was more frequent in positive SN than in negative SN (P < 0.0001). Seven patients had a recurrence, after a mean delay of 17 months (range: 10–26). One of seven patients with a recurrence had an involved SN. HPV DNA was detected in an SN of one of seven patients with recurrence and nine (19.5%) of 46 patients without recurrence (not significant).

Conclusion: In women with cervical cancer, HPV DNA screening of sentinel nodes might help to identify patients at risk of lymph node metastases and recurrence.

Key words: cervical cancer, sentinel lymph node, human papillomavirus, polymerase chain reaction

Received for publication February 9, 2007. Revision received March 26, 2007. Revision received April 6, 2007. Accepted for publication April 11, 2007.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
 J. Clin. Pathol.Home page
G Rasty, J Hauspy, and B Bandarchi
Assessment of sentinel lymph node in cervical cancer: review of literature
J. Clin. Pathol., December 1, 2009; 62(12): 1062 - 1065.
[Abstract] [Full Text] [PDF]


Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.